Sep 12, 2007 (Milwaukee Journal Sentinel - McClatchy-Tribune Information Services via COMTEX) --
A Madison company that is developing products that can rapidly identify bacteria and other organisms will announce today it has raised $23.6 million in a financing led by venture capitalist firms on both coasts.
OpGen Inc.'s third funding round was led by three firms: CHL Medical Partners, Stamford, Conn.; Highland Capital Partners, whose U.S. offices are in Lexington, Mass. and Menlo Park, Calif.; and Versant Ventures, Menlo Park.
